To achieve its goals, the pharmaceutical industry needs a winning strategy. As part of their evolution, pharmaceutical companies must expand their powerful drug improvement offers. In terms of a regulatory framework and tactical innovations, the pharmaceutical industry is at the cutting edge of human knowledge. The length and complexity of these situations make them challenging for businesses and agencies. On the other hand, implementing distribution and enhancement networks may be quite expensive. Strong pharmaceutical techniques are essential to achieving long-term success since they enable connection building, market research, and brand exposure.
The pharmaceutical industry operates in a constantly shifting regulatory environment Health authorities worldwide are continually updating and revising regulations
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers
A Clinical Overview is an integrated document intended to provide critical analysis of Pharmacology Efficacy and Safety of the pharmaceutical agent in humans It is one of the important documents of Module of the Common Technical Document CTD ie Module which refers to the data provided in the comprehensive clinical summary the individual clinical...
The first Biosimilar was approved in the year in the European Union and since then there have been more than biosimilar drugs that have been approved Not surprisingly there has been phenomenal growth in the biosimilars market an Assocham report states that the global biosimilars market is estimated to reach US billion by while the Indian biosimi...
Latest figures show that China is the second pharmaceutical market in the world after the United States with an overall value amounting to about billion dollars in
Against the background of the COVID global pandemic China fasttracked and passed last year its first national biosecurity law Biosecurity Law The law which took effect on April of this year adds another key component to Chinas overall national security
Every life science company is eager to find and absorb industry best practices and for good reason In a business environment that is changing quickly no firm can afford to be left behind and relying on internal experience and lessons is too slow It is essential to imitate as well as to innovate
As companies from Roche to Merck demonstrate successful adaptation begins with a shared vision of the future business model But therein lies the problem What is a business model Despite it being peppered over every meeting and filling the media there is no agreement amongst either academics or executives about the definition of this ubiquitous term
Its been nearly two years since the outbreak of COVID began and were still in the midst of enormous disruptions to the worlds economies businesses education and peoples lives
The drug business has various strange qualities that make it very different from individuals thought process of as industry Its additionally an industry packed with logical inconsistencies for instance notwithstanding the undisputed reality that for more than a century the business has made a major contribution to human prosperity and the decrease...
